Jasmonic acid methyl ester induced tamarind adventitious root extract phospholipid nano-material as well as preparation method, application and pharmaceutical composition of tamarind adventitious root extract phospholipid nano-material

Through methyl jasmonate induction and phospholiposome embedding technology, the problem of poor stability and water solubility of the lacquer wood root extract was solved, and its bioavailability and pharmacological activity were improved, thus achieving the improvement of anti-inflammatory and anti-tumor effects. , and simplifies the preparation process.

CN118903230AActive Publication Date: 2024-11-08NINGBO INST OF TECH ZHEJIANG UNIV ZHEJIANG
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410963426.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-08
Estimated Expiration
2044-07-18

AI Technical Summary

Technical Problem

The stability and water solubility of the yellow-lacquered wood root extract is poor, which affects its bioavailability and pharmacological activity. The seed production time is long, making it difficult to plant in other areas.

Method used

Through methyl jasmonate induction and combined with phospholipid embedding technology, phospholipid nanomaterial induced by methyl jasmonate was prepared, which improved its water solubility and stability, and improved bioavailability and pharmacological activity. .

Benefits of technology

The anti-inflammatory and anti-tumor activity of the methyl jasmonate-induced yellow-lacquered wood root extract was significantly improved, the drug delivery efficiency was enhanced, the material storage and thermal stability were improved, and the preparation cost was reduced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903230A_ABST
    Figure CN118903230A_ABST
Patent Text Reader

Abstract

The invention provides a jasmonic acid methyl ester induced yellowish-lacquer wood adventitious root extract phospholipid nanometer material as well as a preparation method and application thereof and a pharmaceutical composition, and relates to the technical field of biomedicine. The jasmonic acid methyl ester induced taekwood adventitious root extract phospholipid nanometer material provided by the invention comprises a taekwood adventitious root extract induced by jasmonic acid methyl ester and phospholipid bonded on the surface of the taekwood adventitious root extract induced by jasmonic acid methyl ester. According to the invention, the jasmonic acid methyl ester induced tabasheer adventitious root extract is bonded with phospholipid, so that the stability, water solubility, bioavailability and pharmacological activity of the jasmonic acid methyl ester induced tabasheer adventitious root extract are greatly improved, and the anti-inflammatory and anti-tumor activity is excellent. The phospholipid toxicity is small, and the safety of the yellowish-lacquer wood adventitious root extract phospholipid nanometer material induced by the methyl ruellate is high. The phospholipid nano material of the yellowish-lacquer wood adventitious root extract induced by methyl slate is a nano-scale biological material, so that the drug delivery efficiency is greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biomedicine, and in particular to a phospholipid nanomaterial of adventitious root extract of Xanthoceras chinensis induced by methyl jasmonate, a preparation method and application thereof, and a pharmaceutical composition. Background Art

[0002] Dendropanax morbifera, belonging to the Araliaceae family, is an evergreen tree that grows in tropical and subtropical regions, usually as a small understory shrub. The stems of these plants are erect and can grow up to 5 meters tall; the leaves may be unlobed, or have two, three to five lobes. The plants of this genus have a moderate growth rate and can grow up to 1.5 feet (about 45 cm) per year. The flowers are yellow-green, the smooth bark is pale yellow-gray, and the umbels can reach 0.4 inches (about 1 cm) in diameter. Plants of this genus usually like to grow on well-drained soil and prefer partial shade. Different parts of the plant (such as seeds, leaves, roots, and stems) have been used in traditional medicine to treat headaches, infectious diseases, skin problems, and other diseases, and are registered with the Korean Ministry of Food and Drug Safety (KFMDS). Dendropanax morbifera contains polyphenols, essential oils, phenols, flavonoids, tannins, terpenes, and alkaloids. Previous studies have identified a variety of biological activities of P. truncatum such as antioxidant, anti-inflammatory, memory-enhancing, neuroprotective, anticancer, antidiabetic, hepatoprotective, immunomodulatory, antimalarial, cytotoxic, and larvicidal functions.

[0003] The seeds of the yellow lacquer wood have a low tolerance to cold stress. The harvesting of seeds requires a flowering and fruiting period of more than 6 years. In addition, it was noted that the seeds obtained through long-term breeding methods showed a relatively low germination rate. Due to the geographical limitations of the growing environment of the yellow lacquer wood, it is difficult to plant in other areas, and seed production takes a longer time. In vitro reproduction of yellow lacquer wood species, especially research on compounds obtained from in vitro propagation materials Jasmonic acid (JA) and its derivative methyl jasmonate (MeJA) are plant hormones and are widely used in induction studies in in vitro culture systems. Studies have found that methyl jasmonate can effectively increase the content of 3,5-dicaffeoylquinic acid in the adventitious roots of yellow lacquer wood, and the increase of this compound significantly enhances the anti-inflammatory and anti-lung cancer efficacy of the adventitious root extract of yellow lacquer wood.

[0004] The adventitious roots of the yellow lacquer tree contain polyphenols, flavonoids, terpenes and alkaloid compounds, which are relatively fragile in physical and chemical properties, or insoluble in water systems, or have negative effects. Improving the stability, water solubility and bioavailability of the adventitious root extract of the yellow lacquer tree has important application value. Summary of the invention

[0005] In view of this, the purpose of the present invention is to provide a methyl jasmonate-induced yellow lacquerwood adventitious root extract phospholipid nanomaterial and its preparation method and application, and pharmaceutical composition. The methyl jasmonate-induced yellow lacquerwood adventitious root extract phospholipid nanomaterial provided by the present invention has strong stability, good water solubility and high bioavailability.

[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0007] The invention provides a methyl jasmonate-induced yellow lacquerwood adventitious root extract phospholipid nanomaterial, comprising the yellow lacquerwood adventitious root extract induced by methyl jasmonate and phospholipids bonded on the surface of the yellow lacquerwood adventitious root extract induced by methyl jasmonate.

[0008] Preferably, the mass ratio of the extract of the adventitious roots of the methyl jasmonate-induced Psoralea corylifolia to phospholipids is 1:0.5-3.

[0009] Preferably, the phospholipid is a natural phospholipid and / or a synthetic phospholipid; the natural phospholipid includes one or more of soybean lecithin, egg yolk lecithin and phosphatidylcholine.

[0010] The present invention provides a method for preparing a phospholipid nanomaterial from the adventitious root extract of Psoralea corylifolia induced by methyl jasmonate as described in the above technical solution, comprising the following steps:

[0011] The adventitious root extract solution induced by methyl jasmonate and the phospholipid solution are mixed, and the solvent is removed, water is dissolved and compounded in sequence to obtain the phospholipid nanomaterial of the adventitious root extract of the methyl jasmonate-induced strychnos nux vomica.

[0012] Preferably, the solvent in the solution of the adventitious root extract of the yellow lacquer tree induced by methyl jasmonate includes one or more of tetrahydrofuran, dichloromethane, chloroform, n-hexane, ethanol, ethyl acetate, cyclohexane, methanol, isopropanol, n-butanol and acetone; and the concentration of the solution of the adventitious root extract of the yellow lacquer tree induced by methyl jasmonate is 1 to 10 g / L.

[0013] Preferably, the solvent in the phospholipid solution includes one or more of dichloromethane, chloroform and ethyl acetate; the concentration of the phospholipid solution is 1-10 g / L.

[0014] Preferably, the mixing temperature is 25 to 45°C and the mixing time is 1 to 30 minutes;

[0015] The compounding time is 1 to 2 hours, and the compounding is carried out under shaking conditions, and the shaking speed is 60 to 100 rpm.

[0016] Preferably, after the compounding, the method further comprises: subjecting the obtained composite system to ultrasonic treatment, water dialysis and drying in sequence.

[0017] The present invention provides the use of the phospholipid nanomaterial of the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate described in the above technical scheme or the phospholipid nanomaterial of the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate prepared by the preparation method described in the above technical scheme in preparing medicine.

[0018] The present invention provides a pharmaceutical composition, comprising an active component and a pharmaceutically acceptable excipient, wherein the active component comprises the phospholipid nanomaterial of the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate described in the above technical scheme or the phospholipid nanomaterial of the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate prepared by the preparation method described in the above technical scheme.

[0019] The invention provides a methyl jasmonate-induced jasmine wood adventitious root extract phospholipid nanomaterial (MeJA-DMARE-Phytosome), comprising methyl jasmonate-induced jasmine wood adventitious root extract (MeJA-DMARE) and phospholipids bonded to the surface of the methyl jasmonate-induced jasmine wood adventitious root extract.

[0020] Phospholipids have amphiphilic properties, that is, they have both a hydrophilic head and a hydrophobic tail. The present invention embeds the adventitious root extract of yellow lacquer wood induced by methyl jasmonate in phospholipids, which can form a lipid-compatible molecular structure in a non-polar solvent, greatly improving the water solubility of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate. Phospholipids not only serve as carriers, but also have a variety of therapeutic properties. When applied to a drug system in which the adventitious root extract of yellow lacquer wood induced by methyl jasmonate is an active ingredient, a double product effect can be produced, and the biological activity, bioavailability and pharmacological activity of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate can be improved. The anti-inflammatory and anti-tumor activities of the phospholipid nanomaterials of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate are high. The lipid-based nanoparticle system of the phospholipid nanomaterial of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate provided by the present invention, as one of the most promising colloidal carriers of bioactive organic compounds, has excellent time stability (i.e., storage stability) and thermal stability, high loading capacity, and greatly improves the efficiency of drug delivery. Moreover, the extract of the adventitious roots of the yellow lacquer tree induced by methyl jasmonate and the polar phosphatidyl groups are not simply physically mixed, but are bonded by hydrogen bonds, which greatly improves the stability of the phospholipid nanomaterials of the adventitious roots of the yellow lacquer tree induced by methyl jasmonate. Moreover, phospholipids have low toxicity, and the phospholipid nanomaterials of the adventitious roots of the yellow lacquer tree induced by methyl jasmonate are highly safe.

[0021] The invention provides a method for preparing a phospholipid nanomaterial of adventitious root extract of Xanthoceras chinensis induced by methyl jasmonate, which has simple process, simple operation, easy preparation, low manufacturing cost, high benefit and easy large-scale industrial production. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is a diagram showing the Tyndall effect of phospholipid nanomaterials aqueous solution of adventitious root extract of Psoralea corylifolia induced by methyl jasmonate;

[0023] Figure 2 The scanning electron microscopy images (A and B) and transmission electron microscopy images (C and D) of phospholipid nanomaterials extracted from adventitious roots of Psoralea corylifolia induced by methyl jasmonate;

[0024] Figure 3 The dynamic light scattering analysis results of the phospholipid nanomaterials extracted from the adventitious roots of Psoralea corylifolia induced by methyl jasmonate, wherein A is the particle size distribution diagram and B is the zeta potential diagram;

[0025] Figure 4 The UV-visible spectra of the adventitious root extract of Psoralea corylifolia induced by methyl jasmonate, the phospholipid nanomaterials of the adventitious root extract of Psoralea corylifolia induced by methyl jasmonate, and phosphatidylcholine;

[0026] Figure 5 The infrared spectra of the adventitious root extract of Psoralea corylifolia induced by methyl jasmonate, the phospholipid nanomaterials of the adventitious root extract of Psoralea corylifolia induced by methyl jasmonate and phosphatidylcholine;

[0027] Figure 6 This is a graph showing the inhibitory effect of methyl jasmonate-induced adventitious root extract of Xanthoceras chinensis and methyl jasmonate-induced phospholipid nanomaterials of Xanthoceras chinensis adventitious root extract on NO production in RAW cells;

[0028] Figure 7 This is a graph showing the inhibitory effect of methyl jasmonate-induced adventitious root extract of Xanthoceras chinensis and methyl jasmonate-induced adventitious root extract phospholipid nanomaterials on ROS generation in RAW cells;

[0029] Figure 8 The graphs are the inhibitory expression results of the extract of the adventitious roots of the yellow lacquer tree induced by methyl jasmonate and the phospholipid nanomaterials of the extract of the adventitious roots of the yellow lacquer tree induced by methyl jasmonate on the levels of inflammation-related cytokines, wherein A is the agarose gel electrophoresis band diagram of the mRNA gene, B is the mRNA expression diagram of the IL-6 gene, C is the mRNA expression diagram of the iNOS gene, D is the mRNA expression diagram of the TNF-α gene, E is the mRNA expression diagram of the COX-2 gene, and F is the mRNA expression diagram of the IL-1β gene;

[0030] Fig. 9 The results of the promotion effect of methyl jasmonate-induced adventitious root extract of Xanthoceras chinensis and methyl jasmonate-induced phospholipid nanomaterials of Xanthoceras chinensis adventitious root extract on ROS generation in A549 lung cancer cells;

[0031] Fig.10 The graphs are the results of the inhibitory effect of the extract of the adventitious roots of Psoralea corylifolia induced by methyl jasmonate and the phospholipid nanomaterials of the extract of the adventitious roots of Psoralea corylifolia induced by methyl jasmonate on the migration of A549 lung cancer cells, wherein A is the migration graph of A549 lung cancer cells, and B is the migration amount graph of A549 lung cancer cells;

[0032] Fig.11 The figures show the regulatory effect of methyl jasmonate-induced extract of adventitious roots of Xanthoceras chinensis and methyl jasmonate-induced phospholipid nanomaterials of extract of adventitious roots of Xanthoceras chinensis on the expression of apoptotic genes in A549 lung cancer cells, wherein A and F are agarose gel electrophoresis band diagrams of mRNA genes (from left to right are control, MeJA-DMARE and MeJA-DMARE-phytosome), B is the mRNA expression diagram of Caspase 3 gene, C is the mRNA expression diagram of Bax gene, D is the mRNA expression diagram of Bcl-2 gene, E is the mRNA expression diagram of Caspase 9 gene, G is the mRNA expression diagram of p38 gene, H is the mRNA expression diagram of JNK gene, I is the mRNA expression diagram of Nrf2 gene, J is the mRNA expression diagram of HO-1 gene, and K is the mRNA expression diagram of CAT gene. DETAILED DESCRIPTION

[0033] The invention provides a methyl jasmonate-induced smilax china adventitious root extract phospholipid nanomaterial, comprising the methyl jasmonate-induced smilax china adventitious root extract (denoted as MeJA-DMARE) and phospholipids bonded to the surface of the methyl jasmonate-induced smilax china adventitious root extract.

[0034] In the present invention, the mass ratio of the methyl jasmonate-induced adventitious root extract of Psoralea corylifolia to phospholipids is preferably 1:0.5-3, more preferably 1:1-2.5, further preferably 1:1.5-2, and particularly preferably 1:1, 1:2 or 1:3.

[0035] In the present invention, the phospholipid is preferably a natural phospholipid and / or a synthetic phospholipid; the natural phospholipid preferably includes one or more of soybean lecithin, egg yolk lecithin and phosphatidylcholine, and more preferably phosphatidylcholine. In the present invention, the synthetic phospholipid preferably includes one or more of soybean lecithin, egg yolk lecithin and phosphatidylcholine, and more preferably phosphatidylcholine.

[0036] In the present invention, the bonding is preferably through hydrogen bonding.

[0037] The present invention provides a method for preparing a phospholipid nanomaterial of the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate according to the above technical scheme, comprising the following steps: mixing a solution of the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate and a phospholipid solution, and sequentially performing solvent removal, water dissolution and compounding to obtain the phospholipid nanomaterial of the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate.

[0038] Unless otherwise specified, the materials and equipment used in the present invention are all commercially available products in the art.

[0039] In the present invention, the solvent in the solution of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate preferably includes one or more of tetrahydrofuran, dichloromethane, chloroform, n-hexane, ethanol, ethyl acetate, cyclohexane, methanol, isopropanol, n-butanol and acetone, and more preferably methanol or ethanol. In the present invention, the concentration of the adventitious root extract solution of yellow lacquer wood induced by methyl jasmonate is preferably 1-10g / L, more preferably 2-6g / L, and further preferably 2-5g / L. In the present invention, the adventitious root extract solution of yellow lacquer wood induced by methyl jasmonate is preferably obtained by dissolving the adventitious root extract of yellow lacquer wood induced by methyl jasmonate in a solvent; the dissolution temperature is preferably room temperature; the dissolution is preferably carried out under stirring conditions, and the present invention has no special limitation on the stirring time, subject to obtaining a clear and transparent liquid; specifically, stirring for 1-30min, more preferably 5-10min.

[0040] In the present invention, the preparation method of the adventitious root extract of the yellow lacquer wood induced by methyl jasmonate preferably comprises the following steps: mixing the adventitious root powder of the yellow lacquer wood induced by methyl jasmonate with an extractant, extracting, concentrating the obtained extract and drying it to obtain the adventitious root extract of the yellow lacquer wood induced by methyl jasmonate. In the present invention, the adventitious root powder of the yellow lacquer wood induced by methyl jasmonate is preferably obtained by drying, grinding and sieving the adventitious roots of the yellow lacquer wood induced by methyl jasmonate in sequence; the sieving is preferably through a 100-mesh sieve, and the part under the sieve is the adventitious root powder of the yellow lacquer wood induced by methyl jasmonate. In the present invention, the methyl jasmonate-induced Dendropanax morbifera adventitious roots are preferably prepared according to the document "Xu, F.; Valappil, AK; Zheng, S.; Zheng, B.; Yang, D.; Wang, Q. 3,5-DCQA as a Major Molecule in MeJA-Treated Dendropanax morbifera Adventitious Root to Promote Anti-Lung Cancer and Anti-Inflammatory Activities. Biomolecules 2024, 14, 705." In the present invention, the solid-liquid ratio of the methyl jasmonate-induced Dendropanax morbifera adventitious root powder to the extractant is preferably 1 g: 20-40 mL, more preferably 1 g: 30-40 mL; the extractant preferably includes an ethanol aqueous solution, and the volume fraction of ethanol in the ethanol aqueous solution is preferably 30-80%, more preferably 60-70%. In the present invention, the extraction temperature is preferably 40 to 80°C, more preferably 60 to 80°C; the number of extractions is preferably 1 to 5 times, more preferably 2 to 4 times, and further preferably 3 times; the time for a single extraction is preferably 1 to 3 hours, more preferably 1 to 2 hours. In the present invention, the concentration is preferably evaporation, the evaporation temperature is preferably 30 to 60°C, more preferably 40 to 50°C; the evaporation pressure is preferably 10 to 60 MPa, more preferably 20 to 30 MPa. The present invention does not specifically limit the drying temperature and time, as long as the solvent can be completely removed.

[0041] In the present invention, the solvent in the phospholipid solution preferably includes one or more of dichloromethane, chloroform and ethyl acetate, and chloroform is more preferred. In the present invention, the concentration of the phospholipid solution is preferably 1-10 g / L, more preferably 2-6 g / L, and specifically preferably 2 g / L, 4 g / L or 6 g / L. In the present invention, the phospholipid solution is preferably obtained by dissolving phospholipids in a solvent; the dissolution temperature is preferably room temperature; the dissolution is preferably carried out under stirring; the present invention has no special limitation on the stirring time, which is based on obtaining a clear and transparent liquid; specifically, 1-30 min, more preferably 5-10 min.

[0042] In the present invention, the mass ratio of the methyl jasmonate-induced Sedum chinense adventitious root extract in the methyl jasmonate-induced Sedum chinense adventitious root extract solution to the phospholipids in the phospholipid solution is preferably 1:0.5-3, more preferably 1:1-2.5, further preferably 1:1.5-2, and specifically preferably 1:1, 1:2 or 1:3.

[0043] In the present invention, the mixing temperature is preferably 25 to 45° C., more preferably 30 to 35° C.; the mixing time is preferably 1 to 30 min, more preferably 5 to 10 min; and the mixing is preferably performed under stirring conditions.

[0044] In the present invention, the desolventizing preferably includes rotary evaporation desolventizing, and the temperature of the desolventizing is preferably 30-60°C, more preferably 35-45°C, specifically preferably 30°C, 35°C, 36°C, 40°C, 45°C, 50°C, 55°C or 60°C; the present invention does not specifically limit the time of the desolventizing, and is based on the formation of a layer of attachment film visible to the naked eye (the solvent is completely removed).

[0045] In the present invention, the water for water dissolution preferably includes deionized water; the water dissolution is preferably carried out under ultrasonic conditions, and the temperature of the ultrasonic is preferably room temperature; the present invention has no special limitation on the time of the ultrasonic treatment, and the ultrasonic treatment can be performed until the attached film is completely dissolved. The present invention has no special limitation on the amount of water used, and the amount of water used can be sufficient to dissolve the adventitious root extract of the yellow lacquer wood induced by methyl jasmonate, specifically 1 to 10 g / L.

[0046] In the present invention, the temperature of the compounding is preferably room temperature, the time of the compounding is preferably 1 to 2 hours, more preferably 1 to 1.5 hours; the compounding is preferably carried out under shaking conditions, the shaking speed is preferably 60 to 100 rpm, more preferably 70 to 80 rpm; the shaking is preferably carried out on a shaker.

[0047] After completing the compounding, the present invention preferably further comprises: subjecting the obtained composite system to ultrasonic treatment, water dialysis and drying in sequence to obtain the methyl jasmonate-induced yellow lacquer wood adventitious root extract phospholipid nanomaterial. In the present invention, the temperature of the ultrasonic treatment is preferably room temperature, and the time is preferably 10 to 60 minutes, more preferably 20 to 30 minutes; the purpose of the ultrasonic treatment is to disperse the complex evenly. In the present invention, the molecular weight cutoff of the water dialysis is preferably 6000 to 8000Da, more preferably 6500 to 7500Da, and further preferably 7000Da; the time of the water dialysis is preferably 1 to 3h, more preferably 2h. In the present invention, the drying preferably includes spray drying or freeze drying, more preferably freeze drying; the present invention has no special restrictions on the conditions of the drying, as long as the solvent can be completely removed.

[0048] The present invention provides the use of the phospholipid nanomaterial of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate described in the above technical scheme or the phospholipid nanomaterial of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate obtained by the preparation method described in the above technical scheme in the preparation of drugs. In the present invention, the drug preferably includes an anti-inflammatory drug or an anti-tumor drug; the tumor preferably includes lung cancer. In the phospholipid nanomaterial of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate provided by the present invention, the adventitious root extract of yellow lacquer wood induced by methyl jasmonate is wrapped by phospholipids, which greatly improves the solubility of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate, promotes its bioavailability, and has good anti-inflammatory and anti-cancer effects. Moreover, the phospholipid nanomaterial of the adventitious root extract of yellow lacquer wood induced by methyl jasmonate provided by the present invention is a nano-scale biomaterial, which greatly improves the efficiency of drug delivery.

[0049] The present invention also provides a pharmaceutical composition, comprising an active ingredient and a pharmaceutically acceptable excipient, wherein the active ingredient is the phospholipid nanomaterial of the adventitious root extract of the yellow lacquer wood induced by methyl jasmonate described in the above technical solution or the phospholipid nanomaterial of the adventitious root extract of the yellow lacquer wood induced by methyl jasmonate obtained by the preparation method described in the above technical solution. The present invention has no special restrictions on the pharmaceutically acceptable excipients, and pharmaceutically acceptable excipients well known to those skilled in the art can be used. The present invention has no special restrictions on the content of the active ingredient in the pharmaceutical composition, the pharmaceutical dosage form, and the preparation method of the pharmaceutical composition, and the content of the active ingredient in the pharmaceutical composition, the pharmaceutical dosage form, and the preparation method of the pharmaceutical composition known to those skilled in the art can be used.

[0050] To further illustrate the present invention, the following detailed description is given of a methyl jasmonate-induced phospholipid nanomaterial from the adventitious roots of Psoralea corylifolia provided by the present invention, as well as its preparation method, application, and pharmaceutical composition in conjunction with the examples. However, these should not be construed as limiting the scope of protection of the present invention.

[0051] Example 1

[0052] The harvested adventitious roots of the yellow lacquer tree induced by methyl jasmonate were dried, ground, and passed through a 100-mesh sieve. The sieved portion was the powder of the yellow lacquer tree induced by methyl jasmonate. The powder of the yellow lacquer tree induced by methyl jasmonate was mixed with a 70 vol% ethanol aqueous solution, and ultrasonically extracted for 1 h at 80°C. The supernatant was collected by centrifugation each time, and extracted 3 times in total. The supernatants were combined and distilled and dried to constant weight at 10-60 MPa and 30-60°C to obtain the extract of the yellow lacquer tree induced by methyl jasmonate (MeJA-DMARE). Among them, the solid-liquid ratio of the yellow lacquer tree adventitious root powder induced by methyl jasmonate to the 70 vol% ethanol aqueous solution for a single extraction was 1 g:40 mL.

[0053] The extract of the adventitious roots of the yellow lacquer wood induced by methyl jasmonate and methanol were magnetically stirred until clear and transparent to obtain a MeJA-DMARE solution with a concentration of 10 mg / mL. Phosphatidylcholine (PC) was stirred with chloroform until it was clear and transparent to obtain a PC solution with a concentration of 2 mg / mL. The MeJA-DMARE solution and the PC solution were magnetically stirred at 30°C for 10 minutes, and the solvent was evaporated at 60MPa and 45°C. Deionized water was added and ultrasonicated until the film was completely dissolved in the deionized water to obtain a mixed aqueous solution (MeJA-DMARE concentration was 2 mg / mL). The mixed aqueous solution was placed on a shaker and shaken at room temperature (25°C) and 70rpm for 1 hour, followed by ultrasonic water bath for 20 minutes, and dialyzed for 2 hours using a dialysis membrane transferred to 6000-8000Da water. The dialyzed solution was freeze-dried to constant weight to obtain the phospholipid nanomaterial (MeJA-DMARE-Phytosome, complex) of the adventitious root extract of the yellow lacquer wood induced by methyl jasmonate. Among them, the mass ratio of MeJA-DMARE and PC is 1:1.

[0054] The embedding efficiency of MeJA-DMARE-Phytosome prepared in this example for MeJA-DMARE was 43.14±2.86%, and the drug loading was 36.50±3.64%. The embedding efficiency and drug loading of the complex were determined by ultracentrifugation. The specific steps are as follows: 1 mg of MeJA-DMARE-Phytosome was centrifuged at 4°C and 15000 rpm for 90 min using a refrigerated centrifuge. The supernatant λ was measured by using a UV-visible spectrophotometer. max = absorbance at 310 nm and use the calibration curve (concentration range 0.05-1 mg / mL, R 2=0.998 (n=3)) to determine the amount of MeJA-DMARE, the linear regression equation is y=3.2607x+0.0305. Embedding rate=(actual measured mass content of MeJA-DMARE in MeJA-DMARE-Phytosom / theoretical mass content of MeJA-DMARE in MeJA-DMARE-Phytosom)×100%. Drug loading=(actual measured mass of MeJA-DMARE in MeJA-DMARE-Phytosom / mass of MeJA-DMARE-Phytosom)×100%.

[0055] Example 2

[0056] The phospholipid nanomaterials of adventitious root extract of Psoralea corylifolia induced by methyl jasmonate were prepared according to the method of Example 1, and the only difference from Example 1 was that the solvent in the MeJA-DMARE solution was ethanol; the concentration of the PC solution was 6 mg / mL; and the mass ratio of MeJA-DMARE to PC was 1:3. The encapsulation efficiency of the prepared MeJA-DMARE-Phytosome for MeJA-DMARE was 57.90±1.87%, and the drug loading was 54.98±4.90%.

[0057] Example 3

[0058] The phospholipid nanomaterials of adventitious root extract of Psoralea corylifolia induced by methyl jasmonate were prepared according to the method of Example 1, and the only difference from Example 1 was that the concentration of PC solution was 4 mg / mL; the mass ratio of MeJA-DMARE to PC was 1:2. The encapsulation efficiency of the prepared MeJA-DMARE-Phytosome for MeJA-DMARE was 79.98±1.45%, and the drug loading was 69.17±0.14%.

[0059] Test Example 1

[0060] (1) Tyndall effect

[0061] The Tyndall effect is a phenomenon that often occurs in colloidal solutions. The prepared complex was tested using the Tyndall effect. The Tyndall effect can be used to infer the dispersion of MeJA-DMARE-Phytosome. The results are shown in Figure 1 It can be seen that the bright light beam can penetrate the MeJA-DMARE-Phytosome aqueous solution visually, which can preliminarily determine that MeJA-DMARE-Phytosome is a colloid and the particles are evenly distributed.

[0062] (2) Scanning electron microscope

[0063] The shape, morphology and distribution of MeJA-DMARE-Phytosome were determined by field emission transmission microscopy (FE-TEM) and field emission scanning electron microscopy (FE-SEM). Figure 2 A and B in the figure, transmission electron microscopy images are shown in Figure 2 C and D. From the SEM images, it can be seen that the liposome-like vesicles present a bound structure, uniform size, and good dispersion. The transmission electron scanning image shows that the MeJA-DMARE-Phytosome is spherical-translucent in shape, self-enclosed, with a rough surface and no signs of particle aggregation. Apparently, MeJA-DMARE (MeJA-DMARE) forms a spherical structure when it binds to phosphatidylcholine (PC).

[0064] (3) Dynamic light scattering results analysis

[0065] The size distribution, particle dispersion coefficient and zeta potential difference of MeJA-DMARE-Phytosome in water were evaluated using an ELS-Z2 series particle size analyzer at 25°C. Figure 3 , where A is the particle size distribution diagram and B is the zeta potential diagram. The results show that the prepared MeJA-DMARE-Phytosome has an average particle size of 210nm, a small particle size, uniform size distribution, a small dispersion coefficient (0.16), and an excellent zeta potential (-25.19mV).

[0066] (4) UV spectrum scanning

[0067] The ultraviolet absorption spectrum can reflect the changes in the unsaturated bonds of the compound. MeJA-DMARE, MeJA-DMARE-Phytosome and phosphatidylcholine were made into ethanol solutions of the same concentration and scanned by ultraviolet-visible spectroscopy. The results are shown in Figure 4 It can be seen that phosphatidylcholine has a characteristic absorption peak at 235nm, MeJA-DMARE has a maximum absorption peak at 310nm, and MeJA-DMARE-Phytosome also has a maximum absorption peak at this wavelength, but the peak value is not as high as that of MeJA-DMARE of the same concentration. This proves that MeJA-DMARE-Phytosome has no change in chemical structure and mainly exhibits the chemical characteristics of MeJA-DMARE. However, because the characteristic structure may be involved in the binding of MeJA-DMARE with phospholipids, the peak value of the characteristic peak has decreased.

[0068] (5) Infrared spectrum scanning

[0069] Infrared spectroscopy is an absorption spectrum for studying molecular motion. The functional group information of the compound can be inferred based on the position and shape of the absorption peak in the infrared spectrum. MeJA-DMARE-Phytosome was further characterized using Fourier transform infrared (FTIR) spectroscopy to study the interaction between the functional groups on MeJA-DMARE-Phytosome. For FTIR characterization, the dried plant extract, MeJA-DMARE-Phytosome and PC powder were concentrated at 4000-450 cm -1 Scanning within a range of 4 cm -1 , the results are shown in Figure 5 It can be seen that the fingerprint area (below 1500cm -1 ) indicated the generation of a new plant MeJA-DMARE-Phytosome. The spectrum at 3439cm -1 The spectrum shows a peak at 2932 cm, indicating the presence of aliphatic alcohol (-OH) groups commonly found in polyphenolic compounds. -1 and 2957cm -1 The presence of long-chain fatty acid bands at 1463 cm further indicates the formation of phospholipids. -1 ) and POC(1055cm -1 ) The peak corresponding to the phospholipid bond is at the phospholipid bond P=O (1463cm -1 ) and phospholipid bond POC (1055cm -1 ) are shifted to 1469cm -1 and 1074cm -1 Unlike plant extracts, the MeJA-DMARE-Phytosome spectrum showed synergistic effects on its components. For example, with OH (3439 cm -1 ) and C=O (1644 cm -1 ) are related to the characteristic signals at 3476 cm -1 and 1652cm -1 The peaks at 100 nm and 100 nm were merged into a new peak. It can be inferred that hydrogen bonds were formed between the OH groups of the plant extract and the polar groups of the phospholipids. Therefore, these relatively weak intermolecular interactions may be a contributing factor to the formation of MeJA-DMARE-Phytosome.

[0070] Test Example 2

[0071] Inhibitory effects of MeJA-DMARE, PC and MeJA-DMARE-Phytosome on NO production in RAW cells.

[0072] NO plays a role in host defense within the bronchial epithelium and acts as an inflammatory mediator in pathological situations. Nitric oxide is produced in abnormal conditions, including inflammatory bowel disease, arthritis, osteoporosis, and various inflammatory respiratory diseases. Therefore, inhibiting the overproduction of NO has become an important goal in the treatment of inflammatory diseases.

[0073] Cells were stimulated with 1 μg / mL LPS and then incubated for 24 h. After that, RAW264.7 cells were pretreated with different concentrations of MeJA-DMARE and MeJA-DMARE-Phytosome for 1 h. The level of nitrite in the culture medium was assessed using Grise reagent. Briefly, 100 μL of Griess reagent was combined with 100 μL of supernatant. The absorbance at 540 nm was measured. In this experiment, L-NMMA was used as a positive control (standard inhibitor) at a dose of 50 μM. Each group of experiments was repeated 3 times, and the results are shown in Figure 6 .

[0074] Compared with the control group, the production of NO in LPS-treated cells was significantly increased. However, the production of NO in cells induced with MeJA-DMARE and MeJA-DMARE-Phytosome was significantly reduced, even at the lowest tested concentration (31.25 μg / mL), by 40.5% and 38.9%, respectively, compared with LPS-treated cells. In each treatment group, the synthesized MeJA-DMARE-Phytosome of the present invention had a stronger ability to inhibit NO production than the plant extract.

[0075] Test Example 3

[0076] Inhibitory effect of MeJA-DMARE and MeJA-DMARE-Phytosome on ROS generation in RAW cells.

[0077] The cells were stimulated with 1 μg / mL LPS and then incubated for 24 hours. After that, RAW264.7 cells were pretreated with different concentrations of MeJA-DMARE and MeJA-DMARE-Phytosome for 1 hour. After 24 hours of treatment in serum-free medium, the cells were washed three times with PBS and exposed to 20 μM 2',7'-dichloro-dihydrofluorescein diacetate (DCFH-DA) at 37°C in the dark. After that, the medium was removed and the cells were washed twice with 100 μL PBS. The fluorescence intensity of ROS generation was detected. The results are shown in Figure 7 .

[0078] The results showed that the production of ROS was significantly higher in the cells exposed to LPS. In contrast, when LPS-induced cells were treated with MeJA-DMARE and MeJA-DMARE-phytosome, ROS production decreased in a dose-dependent manner. When the concentration of MeJA-DMARE exceeded 125 μg / mL, ROS production was significantly reduced. In each treatment group, the MeJA-DMARE-Phytosome synthesized by the present invention showed a better ability to inhibit ROS production in LPS-induced RAW264.7 cells compared with the plant extract.

[0079] Test Example 4

[0080] MeJA-DMARE and MeJA-DMARE-Phytosome inhibit the expression of inflammation-related cytokine levels.

[0081] LPS-induced gene expression is controlled by a series of signaling pathways, including nuclear factor NF-κB, mitogen-activated protein kinases (MAPKs), and signal transducers and activators of transcription (STAT). NF-κB plays an important role in the occurrence of inflammatory diseases and in regulating the transcription of inflammatory mediators such as iNOS, COX-2, TNF-α, and IL-1β. Macrophages highly express inducible NOS (iNOS), which is responsible for the synthesis of NO. The effects of MeJA-DMARE-phytosome on the expression of these factors were studied by RT-PCR and qRT-PCR. The results are shown in Figure 8 , where A is the agarose gel electrophoresis band diagram of mRNA genes, B is the mRNA expression diagram of IL-6 gene, C is the mRNA expression diagram of iNOS gene, D is the mRNA expression diagram of TNF-α gene, E is the mRNA expression diagram of COX-2 gene, and F is the mRNA expression diagram of IL-1β gene. The results showed that the mRNA expression of COX-2, TNF-α, iNOS, IL-6 and IL-1β in the LPS-treated group was significantly increased (8.86 times, 7.38 times, 11.67 times, 8.70 times and 5.04 times that of the untreated group, respectively). However, compared with the untreated cells, the gene expression of COX-2, TNF-α, iNOS, IL-6 and IL-1β in 250μg / mL MeJA-DMARE-phytosome was reduced by 1.16 times, 2.31 times, 2.37 times, 0.11 times and 2.08 times, respectively.

[0082] It can be seen from the comprehensive test examples 2 to 4 that MeJA-DMARE-Phytosome has an anti-inflammatory effect.

[0083] Test Example 5

[0084] MeJA-DMARE and MeJA-DMARE-Phytosome promote ROS generation in A549 lung cancer cells.

[0085] The ROS content in A549 cells was measured using DCFH-DA. A594 cells were incubated at 37°C and 5% CO2 for 24 h. The harvested cells were treated with 125 μg / mL MeJA-DMARE and MeJA-DMARE-phytosome for 24 h, and the ROS generation was measured. The results are shown in Fig. 9 As shown. The results showed that a dose-dependent increase in intracellular ROS generation was observed in A549 cells after treatment with 250 μg / mL and 500 μg / mL MeJA-DMARE-phytosome compared to the control group. Bioactive compounds can trigger apoptosis of cancer cells by promoting the accumulation of ROS, and MeJA-DMARE-phytosome can promote the generation of ROS. Previous studies have shown that in lung cancer cell lines, MeJA-DMARE-Phytosome has a stronger anti-tumor effect than free polyphenols. The MeJA-DMARE-Phytosome synthesized in the present invention can induce the production of ROS in cancer cells, potentially triggering multiple cell death pathways and ultimately inhibiting the progression of cancer.

[0086] Test Example 6

[0087] Inhibitory effects of MeJA-DMARE and MeJA-DMARE-Phytosome on the migration of A549 lung cancer cells.

[0088] The collective movement of cells in a cohesive manner is a prominent feature of tissue remodeling processes observed in embryonic morphogenesis, wound repair, and cancer invasion. In this type of migration, cells move collectively in the form of sheets, strands, clusters, or ducts. Studies have found that preventing cancer cells from migrating and invading different tissues is a huge challenge for the prevention and treatment of metastatic cancer. A scratch migration assay was used to evaluate the effects of MeJA-DMARE and MeJA-DMARE-phytosome on the migration of A549 cells. In addition, a wound closure assay was performed to evaluate the changes in the migration (%) of A549 lung cancer cells before and after treatment with MeJA-DMARE and MeJA-DMARE-phytosome (at a concentration of 250 μg / mL). The results are shown in the figure. Fig.10As shown, A is the migration diagram of A549 lung cancer cells, and B is the migration amount diagram of A549 lung cancer cells. The results showed that after treatment with MeJA-DMARE and MeJA-DMARE-phytosome, the number of migrating cells decreased, indicating that both inhibited the lateral movement of A549 cells. It is worth noting that MeJA-DMARE-phytosome showed a stronger inhibitory effect than MeJA-DMARE.

[0089] Test Example 7

[0090] Regulatory effects of MeJA-DMARE and MeJA-DMARE-Phytosome on the expression of apoptosis genes in A549 lung cancer cells.

[0091] Fig.11 The figures show the regulatory effect of methyl jasmonate-induced extract of adventitious roots of Xanthoceras chinensis and methyl jasmonate-induced phospholipid nanomaterials of extract of adventitious roots of Xanthoceras chinensis on the expression of apoptotic genes in A549 lung cancer cells, wherein A and F are agarose gel electrophoresis band diagrams of mRNA genes (from left to right are control, MeJA-DMARE and MeJA-DMARE-phytosome), B is the mRNA expression diagram of Caspase 3 gene, C is the mRNA expression diagram of Bax gene, D is the mRNA expression diagram of Bcl-2 gene, E is the mRNA expression diagram of Caspase 9 gene, G is the mRNA expression diagram of p38 gene, H is the mRNA expression diagram of JNK gene, I is the mRNA expression diagram of Nrf2 gene, J is the mRNA expression diagram of HO-1 gene, and K is the mRNA expression diagram of CAT gene.

[0092] Bcl-2 is an anti-apoptotic protein produced in response to DNA damage, which makes it a key player in controlling cell death and serving as an indicator of intracellular genotoxic stress. Fig.11 As shown in the figure, MeJA-DMARE-phytosome significantly down-regulated the expression of Bcl-2 by 0.24 times. On the contrary, the mRNA expression of Caspase 3, Caspase 9 and Bax was significantly up-regulated by 2.37 times, 4.53 times and 6.26 times, respectively. The MeJA-DMARE-phytosome synthesized by the present invention can effectively inhibit the expression of genes related to apoptosis of lung cancer cells.

[0093] On the other hand, heme oxygenase-1 (HO-1) is well known for its strong induction response to various stressors and many cancer chemopreventive drugs. However, in human cancers, overexpression of HO-1 provides cancer cells with a growth advantage, making them more resistant to chemotherapy and photodynamic therapy. Nrf2 is a key transcription factor in defense against oxidative stress, and activation of Nrf2 is an effective strategy to prevent cancer induced by exposure to environmental carcinogens. This activation is thought to be controlled by several upstream signaling kinases, including mitogen-activated protein kinases (MAPKs, such as p38 and JNK), which are able to regulate the activity of Nrf2. As Fig.11 As shown, the mRNA expression levels of p38MAPK and JNK were the lowest in the control group. However, MeJA-DMARE-phytosome significantly upregulated these expressions in A549 lung cancer cells (p38MAPK and JNK increased by 4.52 times and 3.40 times, respectively). In addition, MeJA-DMARE-phytosome was able to significantly downregulate these expressions in A549 lung cancer cells (Nrf2, HO-1 and CAT decreased by 0.37 times, 0.79 times and 0.44 times, respectively).

[0094] It can be seen from the comprehensive test examples 5 to 7 that the MeJA-DMARE-Phytosome synthesized by the present invention has an anti-lung cancer effect.

[0095] Test Case 8

[0096] Stability test

[0097] The in vitro stability of MeJA-DMARE-phytosome prepared in the embodiment was tested in 8 solvents, namely, distilled water, 20 mM glycine-hydrochloric acid buffer (pH = 2.0), citrate-sodium citrate buffer (pH = 5.0), sodium phosphate buffer (pH = 7.0), tris-hydrochloric acid buffer (pH = 8.0), 5 wt% sodium chloride aqueous solution, 10 wt% sodium chloride aqueous solution and 5% bovine serum albumin. The specific steps are as follows: 900 μL of solvent was mixed with 100 μL of MeJA-DMARE-phytosome aqueous solution with a concentration of 10 mg / mL, and incubated at 37° C. for one month. No obvious wavelength shift was observed in the UV-visible spectrum detection, and the wavelength difference was within 4 nm, indicating that within one month, the physicochemical properties of MeJA-DMARE-Phytosome prepared by the present invention were almost unchanged, indicating that MeJA-DMARE-Phytosome has good stability.

[0098] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A methyl jasmonate-induced yellow lacquer tree adventitious root extract phospholipid nanomaterial, comprising a methyl jasmonate-induced yellow lacquer tree adventitious root extract and a phospholipid bonded to the surface of the methyl jasmonate-induced yellow lacquer tree adventitious root extract.

2. The phospholipid nanomaterial of adventitious root extract of Xanthoceras chinensis induced by methyl jasmonate according to claim 1, characterized in that: The mass ratio of the adventitious root extract of Xanthoceras edulis induced by methyl jasmonate to phospholipids is 1:0.5-3.

3. The phospholipid nanomaterial of the adventitious root extract of Psoralea corylifolia induced by methyl jasmonate according to claim 1 or 2, characterized in that: The phospholipids are natural phospholipids and / or synthetic phospholipids; the natural phospholipids include one or more of soybean lecithin, egg yolk lecithin and phosphatidylcholine.

4. The method for preparing the phospholipid nanomaterial of the adventitious root extract of Psoralea corylifolia induced by methyl jasmonate according to any one of claims 1 to 3, comprising the following steps: The adventitious root extract solution induced by methyl jasmonate and the phospholipid solution are mixed, and the solvent is removed, water is dissolved and compounded in sequence to obtain the phospholipid nanomaterial of the adventitious root extract of the methyl jasmonate-induced strychnos nux vomica.

5. The preparation method according to claim 4, characterized in that: The solvent in the solution of the adventitious root extract of the yellow lacquer tree induced by methyl jasmonate includes one or more of tetrahydrofuran, dichloromethane, chloroform, n-hexane, ethanol, ethyl acetate, cyclohexane, methanol, isopropanol, n-butanol and acetone; the concentration of the solution of the adventitious root extract of the yellow lacquer tree induced by methyl jasmonate is 1-10g / L.

6. The preparation method according to claim 4, characterized in that: The solvent in the phospholipid solution includes one or more of dichloromethane, chloroform and ethyl acetate; the concentration of the phospholipid solution is 1-10 g / L.

7. The preparation method according to any one of claims 4 to 6, characterized in that: The mixing temperature is 25 to 45° C. and the mixing time is 1 to 30 minutes; The compounding time is 1 to 2 hours, and the compounding is carried out under shaking conditions, and the shaking speed is 60 to 100 rpm.

8. The preparation method according to claim 7, characterized in that: After the compounding, the method further comprises: sequentially subjecting the obtained compound system to ultrasonic treatment, water dialysis and drying.

9. Use of the phospholipid nanomaterial derived from the adventitious root extract of Xanthoceras erythrorhizon induced by methyl jasmonate as claimed in any one of claims 1 to 3 or the phospholipid nanomaterial derived from the adventitious root extract of Xanthoceras erythrorhizon induced by the preparation method as claimed in any one of claims 4 to 8 in the preparation of medicines.

10. A pharmaceutical composition comprising an active ingredient and a pharmaceutically acceptable excipient, wherein the active ingredient comprises the phospholipid nanomaterial of the extract of the adventitious roots of the strychnos nux vomica induced by methyl jasmonate as described in any one of claims 1 to 3 or the phospholipid nanomaterial of the extract of the adventitious roots of the strychnos nux vomica induced by methyl jasmonate obtained by the preparation method of any one of claims 4 to 8.

Citation Information

Patent Citations

  • Lindera aggregata leaf extract as well as preparation method and application thereof

    CN113197934A

  • Preparation method and application of total flavonoids from torreya grandis epicarp

    CN115039795A

  • Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery

    WO2007115134A2

  • KR20240072538A